Search results for "Guidelines"
Prophylactic injectable monoclonal antibody reduced migraine days, industry trial finds
Compared with nonspecific oral drugs, patients treated with erenumab were six times more likely to achieve 50% or more reduction in monthly migraine days and were 11 times more likely to complete the treatment on the first attempt, authors reported.
https://immattersacp.org/weekly/archives/2024/04/02/4.htm
2 Apr 2024
Treat COPD symptoms, solve problems
Effectively managing chronic obstructive pulmonary disease means staying up to date on medications, devices, and delivery techniques.
https://immattersacp.org/archives/2024/04/treat-copd-symptoms-solve-problems.htm
1 Apr 2024
Too early to tell on sickle cell 'cures'
New therapies for sickle cell disease create an opportunity for primary care physicians to ensure that their adult patients are regularly meeting with a specialist to review treatment options.
https://immattersacp.org/archives/2024/04/too-early-to-tell-on-sickle-cell-cures.htm
1 Apr 2024
Digoxin still used, but toxicity not appreciated
Add digoxin toxicity to your checklist of diagnostic suspicions, and consider standing orders to check serum levels in certain populations.
https://immattersacp.org/archives/2024/04/digoxin-still-used-but-toxicity-not-appreciated.htm
1 Apr 2024
MKSAP Quiz: Evaluation for cough, wheezing
A 35-year-old woman is evaluated for a cough and wheezing occurring several times during the week, unrelated to exercise. She has a history of asthma that was previously well controlled with a budesonide inhaler. She is also taking albuterol five times weekly with good response. Following a physical exam, what treatment should be started?
https://immattersacp.org/weekly/archives/2024/03/26/3.htm
26 Mar 2024
Study identifies factors behind guideline-discordant use of lung cancer screening
Interviews with 31 primary care physicians suggested that knowledge gaps about the life expectancy threshold at which lung cancer screening's value becomes limited may contribute to their decisions to recommend screening to patients who may not benefit.
https://immattersacp.org/weekly/archives/2024/03/19/2.htm
19 Mar 2024
MKSAP Quiz: Left lower pelvic pain
A 62-year-old woman is evaluated for left lower pelvic pain for the last 3 months. Family history is significant for ovarian cancer in her mother at age 51 years and triple-negative breast cancer in her sister at age 42 years. A CT shows an 8-cm left adnexal mass in the pelvis. What is the most appropriate initial management?
https://immattersacp.org/weekly/archives/2024/03/19/3.htm
19 Mar 2024
Antifracture effects of zoledronate persist for up to 3.5 years, study suggests
Fracture rates rose from 15 per 1,000 woman-years in the last two years of a six-year trial to 24 fractures in the first two years of follow-up. In the next two years of follow-up, the rate substantially increased to 42 fractures per 1,000 woman-years.
https://immattersacp.org/weekly/archives/2024/03/12/4.htm
12 Mar 2024
Recommendations released on statin therapy for people with HIV
The guidance from a panel of the U.S. Department of Health and Human Services addresses primary prevention of atherosclerotic cardiovascular disease in patients ages 40 to 75 years and younger than age 40 years.
https://immattersacp.org/weekly/archives/2024/03/05/2.htm
5 Mar 2024
New COVID-19 vaccine recommendations, data on after-effects of infection
The CDC recommended another COVID-19 booster for older patients and ended five-day isolation guidelines, while studies showed that COVID-19 infection was associated with a small cognitive decline and an increase in risk for autoimmune inflammatory rheumatic diseases.
https://immattersacp.org/weekly/archives/2024/03/05/4.htm
5 Mar 2024